Abeona Therapeutics Inc. (ABEO) Social Stream
ABEONA THERAPEUTICS INC (ABEO) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering ABEO.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-15 | 2 | $5 | $5 | $5 | $4.2 | 19.05% |
| 2021-11-18 | 3 | $5 | $5 | $5 | $4.2 | 19.05% |
| 2021-11-29 | 3 | $5 | $4 | $4.666 | $4.2 | 11.1% |
| 2021-11-30 | 3 | $5 | $1 | $3.333 | $4.2 | -20.64% |
| 2022-03-31 | 3 | $4 | $1 | $3 | $4.2 | -28.57% |
| 2022-04-01 | 3 | $4 | $1 | $2.666 | $4.2 | -36.52% |
| 2022-05-13 | 2 | $3 | $1 | $2 | $4.2 | -52.38% |
| 2022-05-18 | 2 | $2 | $1 | $1.5 | $4.2 | -64.29% |
| 2022-07-18 | 2 | $15 | $1 | $8 | $4.2 | 90.48% |
| 2022-11-03 | 2 | $22 | $5 | $13.5 | $4.2 | 221.43% |
| 2022-11-08 | 2 | $40 | $5 | $22.5 | $4.2 | 435.71% |
| 2022-11-15 | 2 | $38 | $6 | $22 | $4.2 | 423.81% |
| 2023-03-30 | 1 | $38 | $38 | $38 | $4.2 | 804.76% |
| 2023-05-12 | 1 | $38 | $10 | $24 | $4.2 | 471.43% |
| 2023-05-30 | 2 | $38 | $10 | $22.666 | $4.2 | 439.67% |
| 2023-08-09 | 2 | $38 | $10 | $21.5 | $4.2 | 411.9% |
| 2023-08-11 | 2 | $38 | $8 | $21 | $4.2 | 400% |
| 2023-08-30 | 2 | $38 | $8 | $20.5 | $4.2 | 388.1% |
The Trend in the Analyst Price Target
Over the past 40 months, ABEO's average price target has gone up $11.07.
ABEO reports an average of 575.57% for its upside potential over the past 44 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-11-08 | 2 | 40 | 5 | 22.5 | 3.81 | 490.55% |
| 2022-11-15 | 1 | 38 | 38 | 38.0 | 4.04 | 840.59% |
| 2023-04-18 | 1 | 38 | 10 | 24.0 | 2.93 | 719.11% |
| 2023-07-11 | 2 | 38 | 10 | 21.5 | 4.10 | 424.39% |
| 2023-07-13 | 2 | 38 | 10 | 21.5 | 3.99 | 438.85% |
ABEO Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1 | 2 | 0 | 0 | 0 | 0 | 2 |
The Trend in the Broker Recommendations
ABEO's average broker recommendation rating improved by 0.33 over the prior 22 months.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- To contextualize these metrics, consider that out of all US stocks, ABEONA THERAPEUTICS INC's number of analysts covering the stock is higher than 73.52% of them.
- ABEO has a lower variance in analysts' estimates than -1295.28% of all US stocks.
- In the context of stocks in the small market cap category, ABEONA THERAPEUTICS INC's upside potential (average analyst target price relative to current price) is higher than 892.61% of them.
- ABEONA THERAPEUTICS INC's average analyst price target is higher than 432.95% of Healthcare stocks.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to ABEONA THERAPEUTICS INC are SELB, ACIU, and SYRS.
View All Top Stocks by Price Target
Make investment decisions regarding ABEO using the data that counts. Try POWR Ratings for free.